(Q46629452)

English

The somatostatin analogue SOM230, compared with octreotide, induces differential effects in several metabolic pathways in acromegalic patients

scientific article published in August 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16060911

The somatostatin analogue SOM230, compared with octreotide, induces differential effects in several metabolic pathways in acromegalic patients (English)

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16060911

Wouter W de Herder

4

object named as

Wouter W de Herder

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16060911

author name string

Joost van der Hoek

1

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16060911

Aart-Jan van der Lelij

2

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16060911

Richard A Feelders

3

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16060911

Piet Uitterlinden

5

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16060911

Kwai W Poon

6

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16060911

Viktor Boerlin

7

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16060911

Ian Lewis

8

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16060911

Tillmann Krahnke

9

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16060911

Leo J Hofland

10

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16060911

Steven W Lamberts

11

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16060911

publication date

1 August 2005

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16060911

Clinical Endocrinology

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16060911

63

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16060911

176-184

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16060911

2

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16060911

Somatostatin receptors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02322.X

21 January 2018

Classification and nomenclature of somatostatin receptors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02322.X

21 January 2018

The somatostatin receptor family.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02322.X

21 January 2018

Results of a European multicentre study with Sandostatin LAR in acromegalic patients. Sandostatin LAR Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02322.X

21 January 2018

A novel somatostatin mimic with broad somatotropin release inhibitory factor receptor binding and superior therapeutic potential.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02322.X

21 January 2018

SOM230: a new somatostatin peptidomimetic with potent inhibitory effects on the growth hormone/insulin-like growth factor-I axis in rats, primates, and dogs

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02322.X

21 January 2018

Reduced activation and increased inactivation of thyroid hormone in tissues of critically ill patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02322.X

21 January 2018

Intensive insulin therapy in critically ill patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02322.X

21 January 2018

New somatostatin analogs: will they fulfil old promises?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02322.X

21 January 2018

Fates of endocytosed somatostatin sst2 receptors and associated agonists

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02322.X

21 January 2018

Regulation and function of insulin-like growth factor-binding protein-1.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02322.X

21 January 2018

Insulin regulates the 35 kDa IGF binding protein in patients with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02322.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02322.X

21 January 2018

Somatostatin receptor subtype 5 regulates insulin secretion and glucose homeostasis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02322.X

21 January 2018

sst2 somatostatin receptor mediates negative regulation of insulin receptor signaling through the tyrosine phosphatase SHP-1.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02322.X

21 January 2018

Identifiers

10.1111/J.1365-2265.2005.02322.X

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16060911

release_khc4imf5ezh25n53acauuqrera

1 reference

https://api.fatcat.wiki/v0/release/khc4imf5ezh25n53acauuqrera

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16060911

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46629452&oldid=2123083056"